Results 221 to 230 of about 168,097 (250)
Some of the next articles are maybe not open access.
Heart Failure With Preserved Ejection Fraction: A Review.
Journal of the American Medical Association (JAMA), 2023Importance Heart failure with preserved ejection fraction (HFpEF), defined as HF with an EF of 50% or higher at diagnosis, affects approximately 3 million people in the US and up to 32 million people worldwide.
M. Redfield, B. Borlaug
semanticscholar +1 more source
Cardiovascular Research, 2022
Obesity and heart failure (HF) with preserved ejection fraction (HFpEF) represent two intermingling epidemics driving perhaps the greatest unmet health problem in cardiovascular medicine in the 21st century. Many patients with HFpEF are either overweight
B. Borlaug +5 more
semanticscholar +1 more source
Obesity and heart failure (HF) with preserved ejection fraction (HFpEF) represent two intermingling epidemics driving perhaps the greatest unmet health problem in cardiovascular medicine in the 21st century. Many patients with HFpEF are either overweight
B. Borlaug +5 more
semanticscholar +1 more source
European Journal of Heart Failure, 2023
Degenerative aortic valve stenosis with preserved ejection fraction (ASpEF) and heart failure with preserved ejection fraction (HFpEF) display intriguing similarities. This study aimed to provide a non‐invasive, comparative analysis of ASpEF versus HFpEF
N. De Biase +12 more
semanticscholar +1 more source
Degenerative aortic valve stenosis with preserved ejection fraction (ASpEF) and heart failure with preserved ejection fraction (HFpEF) display intriguing similarities. This study aimed to provide a non‐invasive, comparative analysis of ASpEF versus HFpEF
N. De Biase +12 more
semanticscholar +1 more source
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity.
New England Journal of MedicineBACKGROUND Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, causes considerable weight loss, but data ...
Milton Packer +12 more
semanticscholar +1 more source
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
New England Journal of MedicineBACKGROUND Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and mildly reduced or preserved ejection fraction ...
Scott D. Solomon +58 more
semanticscholar +1 more source
Heart failure with preserved ejection fraction.
New England Journal of Medicine, 2006A. Ahmed, J. Fleg, M. Gheorghiade
semanticscholar +1 more source
Heart failure with preserved ejection fraction.
Circulation, 2011J. Udelson
semanticscholar +1 more source
Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial
Nature Network Boston, 2021G. Lewis +16 more
semanticscholar +1 more source

